However, treatments with estradiol, the natural ligand of ERβ, also stimulate estrogen receptor alpha (ERα), causing several effects, such as hypertension, cerebrovascular events, myocardial infarction, and ovarian and endometrial cancer [16]. This evidence concerns the gene ESR1 and endometrial cancer.